53533-54-3Relevant academic research and scientific papers
Hepatitis C Virus Inhibitors
-
Page/Page column 140, (2008/12/05)
Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
NOVEL COMPOUNDS HAVING AN ANTIBACTERIAL ACTIVITY
-
Page/Page column 23-24, (2010/02/09)
The invention relates to novel antibacterial compounds of formula (I). Said compounds are of interest, inter alia, as topoisomerase IV (topo IV) and DNA gyrase inhibitors.
HEPATITIS C VIRUS INHIBITORS
-
Page 351-352, (2008/06/13)
Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
Heterocyclic derivatives and their use as antithrombotic agents
-
, (2008/06/13)
The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S; X′ being independently CH or N; and m is 0, 1, 2 or 3; wherein the group Q is bound through an oxygen atom or an optionally substituted nitrogen or carbon atom, or a pharmaceutically acceptable salt thereof or a prodrug thereof. The compounds of the invention are therapeutically active and in particular are antithrombotic agents.
